We are a leader in the development of organ-on-chip biotechnology and innovating the next generation of cellular systems of human diseases. The impact of our research is far reaching as organ-chips mimic complex disease states and offer a testbed for pharmacology and toxicology. This technology is disrupting traditional preclinical practice and gradually reducing animal models from translational research. We also envision organ-chips as a platform with tremendous potential to enable basic scientific discoveries of the future. We particularly specialize in making patient-specific models of rare and orphan diseases with an emphasis on vascular and blood abnormalities.
Our work is internationally recognized through high-impact publications and our patented/patent-pending inventions have been licensed to industry. Our staff and trainees regularly win prestigious fellowships and awards.

News






March 12, 2022

March 3, 2022

February 25, 2022

December 16, 2021

December 10, 2021

News Archive
Quick Navigation
Research, Publications, Patents, People, Facilities, Teaching, Openings